Saturday, April 1, 2023
OANDP-L
  • Login
No Result
View All Result
The O&P EDGE
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
    • EDGE Flipbooks
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
    • EDGE Flipbooks
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
No Result
View All Result
The O&P EDGE Magazine
No Result
View All Result
Home News

Ekso Bionics Reports 4Q, Year-end 2016 Results

by The O&P EDGE
March 13, 2017
in News
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Ekso Bionics Holdings, Richmond, California, reported financial results for the fourth quarter (4Q) and full-year (FY) ended December 31, 2016.

The 4Q 2016 results are as follows:

  • Device and related revenue was $2.3 million. This amount includes $1.5 million for medical device sales during the period, $0.2 million of medical device service revenue, and $0.6 million for industrial sales. This compares to device and related revenue of $1.1 million for 4Q 2015. This amount includes $0.9 million derived from current and prior year sales that was amortized on a straight-line basis during the period and $0.2 million of medical device service revenue.
  • Engineering service revenue was $0.3 million for 4Q 2016 compared to $0.8 million for 4Q 2015. This result reflects the company’s decision earlier in the year to shift engineering resources away from billable engineering services and to internal development efforts.
  • Gross profit for 4Q 2016 of $0.8 million was primarily derived from device and related revenue. This amount includes a gross profit of $0.5 million from medical device sales and service and gross profit of $0.2 million from industrial sales. This compares to a gross loss of $0.2 million for 4Q 2015.
  • Sales and marketing expenses increased $0.3 million, or 14 percent, for 4Q 2016 compared to 4Q 2015, primarily due to increased costs associated with sales and marketing efforts related to industrial products.
  • Research and development expenses increased $0.3 million, or 12 percent, for 4Q 2016 compared to 4Q 2015 due to the shift of resources away from billable engineering services, which were recognized as a cost of engineering services revenue, to internal development efforts for next-generation home mobility and industrial products.
  • General and administrative expenses increased $0.7 million, or 35 percent, for 4Q 2016 compared to 4Q 2015, primarily due to an increase of $0.3 million in employee compensation expenses, an increase of $0.3 million related to a decrease in absorption of operating direct and indirect costs into inventory, and a $0.1 million increase in depreciation and amortization primarily related to acquiring assets from Equipois, Manchester, New Hampshire, in December 2015.

The FY 2016 financial results are as follows:

  • Device and related revenue was $13.3 million. Contributing to this revenue was $6.5 million of previously deferred revenue that was recognized as a result of a change of an accounting estimate related to revenue recognition. Revenue also includes $4.7 million of revenue derived from medical device sales during the period, $0.9 million of medical device service revenues, and $1.2 million of industrial sales revenue. For FY2015, device and related revenue was $4.3 million. This amount includes $3.6 million derived from current and prior year sales that was amortized on a straight-line basis during the period and $0.7 million of medical device service revenue.
  • In conjunction with the aforementioned shift in focus of engineering efforts, engineering services revenue was $0.9 million for FY 2016 compared to $4.4 million in the prior year.
  • Gross profit for FY 2016 was $2.9 million, of which $2.6 million was attributable to device and related revenue. Medical device gross profit was $2.3 million, industrial gross profit was $0.3 million and engineering services gross profit was $0.3 million. The medical gross profit includes $1.2 million related to the change in accounting estimate. Gross profit for FY 2015 was $1.2 million. This amount includes $0.3 million related to medical device sales and $0.9 million for engineering services.
  • Sales and marketing expenses increased $1.7 million, or 19 percent, during FY 2016 compared to FY 2015. The increase includes $1 million related to Ekso’s industrial business. The increase also includes $0.7 million related to the company’s medical device business, which was primarily driven by using consultants for clinical studies, reimbursement and marketing.
  • Research and development expenses increased $2.4 million, or 37 percent, during FY 2016 compared to FY 2015. The increase includes $1.2 million related to the company industrial business, which was primarily driven by a reallocation and increase in headcount. This increase also includes $1.2 million related to the shift of resources from engineering services to internal development efforts.
  • General and administrative expenses increased $3.9 million, or 55 percent, during FY 2016 compared to FY 2015. The increase was primarily driven by an increase of $2.4 million in employee compensation expense, which included a noncash stock-based compensation expense increase of $1.1 million, a one-time severance expense of $0.3 million and an increase in regulatory compliance personnel of $0.3 million. Stock-based compensation expense included a one-time $0.8 million noncash charge related to the modification of stock options previously granted to the company’s former CEO. Depreciation and amortization expenses in general and administrative expenses increased $0.6 million, primarily related to acquiring assets from Equipois. A decrease in absorption of direct and indirect operating costs in inventory in 2016 as compared to 2015 also contributed $0.6 million to the increase in general and administrative expenses.

Net loss applicable to common shareholders in 4Q 2016 was $5.6 million, or a basic net loss of $0.29 per common share. For FY 2016, net loss was $33.8 million, or a basic net loss of $1.87 per common share. Net loss applicable to common shareholders for FY 2016 included a noncash preferred deemed dividend of $10.3 million, partially offset by a noncash gain of $4.3 million on the revaluation of a warrant liability. Both noncash items were associated with the equity financing in December 2015.

Cash on hand on December 31, 2016, was $16.8 million, compared to $19.6 million on December 31, 2015. For FY 2016, the company used $25 million of cash in operations, compared to $18.3 million for FY 2015. The increase in cash used was driven by general increases in operating expenses such as selling, marketing, and research and development. The increase also includes a one-time increase in inventory, as well as some investment in certain inventory.

Related posts:

  1. Ekso Bionics Posts 3Q 2015 Financial Results
  2. Hanger Announces 3Q Results
  3. Hanger Reaffirms 2007 Outlook
  4. Hanger Announces Q2 Results
Previous Post

Prosthetic Care Facility of Virginia Wins Local Award

Next Post

ABC Supports Foundation Creating Center for O&P Excellence

Next Post

ABC Supports Foundation Creating Center for O&P Excellence

  • VIEW CURRENT ISSUE
  • SUBSCRIBE FOR FREE

RECENT NEWS

News

Concerns About 3D-printed O&P Devices Slowing Adoption

by The O&P EDGE
March 24, 2023

A research team in Canada reviewed recent progress in the use of polymer-based additive manufacturing (AM) for 3D printing of...

Read more

van Halem Group Names Director of Business Development

Limb Art Products to Launch in US

Lower-limb Residual Limb Health Measure Also Effective for Upper Limbs

Get unlimited access!

Join EDGE ADVANTAGE and unlock The O&P EDGE's vast library of archived content.
SUBSCRIBE TODAY

O&P JOBS

Eastern

Senior Director – HSS Prosthetics and Orthotics

Pacific

CPO, CP, CO- Department of Orthopaedic Surgery: Pediatric

Central

Research Team Scientist

 

© 2021 The O&P EDGE

  • About
  • Advertise
  • Contact
  • EDGE Advantage
  • OANDP-L
  • Subscribe

CONTACT US

866-613-0257

[email protected]

201 E. 4th St
Loveland, CO 80537

The most important industry news and events delivered directly to your inbox every week.

No Result
View All Result
  • PECOS
  • MAGAZINE
    • SUBSCRIBE
    • CURRENT ISSUE
    • ISSUE ARCHIVE
    • NEWS ARCHIVE
    • PRODUCTS & SERVICES DIRECTORY
    • ADVERTISING INFORMATION
  • O&P JOBS
    • FIND A JOB
    • POST A JOB
  • EDGE ADVANTAGE
  • FACILITES
  • RESOURCES
    • PRODUCTS & SERVICES DIRECTORY
    • CALENDAR
    • CONTACT
    • ABOUT US
    • O&P LIBRARY
    • THE GUIDE
    • CUSTOM PUBLICATIONS
    • ADVERTISING
    • EDGE DIRECT
    • AMPLITUDE
  • OANDP-L
  • LOGIN

© 2023The O&P EDGE

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
The O&P EDGE Magazine
 
Required 'Candidate' login to applying this job. Click here to logout And try again
 

Login to your account

  • Forgot Password? | Sign Up

Reset Password

  • Already have an account? Login

Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.

Signup to your Account

  • By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

    Already have an account? Login

Close
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
 

Account Activation

Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder. Click here to resend the activation email. If you entered an incorrect email address, you will need to re-register with the correct email address.